Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38087
CAS Number:
145525-41-3
Mitiglinide calcique
Purity:
≥ 98 % (HPLC)
Synonym(s):
Sel de calcium de l'acide (a S ,3a R ,7a S )-octahydro-G-oxo-a-(phénylméthyl)-2 H -isoindole-2-butanoïque, Sel hémicalcique de mitiglinide
Documents
$145.52 /100 mg
Taille
Request Bulk Quote
Product Information

Conserver sous gaz inerte

Synonyms
Sel de calcium de l'acide (a S ,3a R ,7a S )-octahydro-G-oxo-a-(phénylméthyl)-2 H -isoindole-2-butanoïque, Sel hémicalcique de mitiglinide
CAS Number
145525-41-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C38H48CaN2O6
Molecular Weight
668.89
MDL Number
MFCD09955408
PubChem ID
53394913
Melting Point
184 - 186 °C
Appearance
Poudre blanche à presque blanche à cristal
Optical Rotation
[a] 20 D = 5 - 9 ° (C=1, MeOH) (calculé sur une substance anh.)
Conditions
Conserver entre 2 et 8 °C
General Information
Synonyms
Sel de calcium de l'acide (a S ,3a R ,7a S )-octahydro-G-oxo-a-(phénylméthyl)-2 H -isoindole-2-butanoïque, Sel hémicalcique de mitiglinide
CAS Number
145525-41-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C38H48CaN2O6
Molecular Weight
668.89
MDL Number
MFCD09955408
PubChem ID
53394913
Melting Point
184 - 186 °C
Appearance
Poudre blanche à presque blanche à cristal
Optical Rotation
[a] 20 D = 5 - 9 ° (C=1, MeOH) (calculé sur une substance anh.)
Conditions
Conserver entre 2 et 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Mitiglinide calcium is widely utilized in research focused on:

  • Diabetes Management: This compound is primarily used in the treatment of type 2 diabetes, helping to regulate blood sugar levels by stimulating insulin secretion from the pancreas.
  • Pharmaceutical Development: Researchers are exploring its potential in developing new formulations that enhance the bioavailability and effectiveness of diabetes medications.
  • Clinical Trials: Mitiglinide calcium is often involved in clinical studies aimed at assessing its long-term effects and safety profiles in diverse patient populations.
  • Combination Therapies: It is being investigated for use in combination with other antidiabetic agents to improve glycemic control and reduce side effects.
  • Patient Education: The compound is also a focal point in educational materials for healthcare providers, emphasizing its role in personalized diabetes care and management strategies.

Citations